ASTH (Astrana Health) E10: $0.55 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASTH Astrana Health Inc ASTH
74 GF Score
Price $37.47
GF Value $65.38
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Astrana Health E10?

Astrana Health ASTH +4.78% 74 E10 is $0.55 as of Jun. 2026. GuruFocus rates ASTH with a GF Score™ of 74/100 and a GF Value™ of $65.38 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Astrana Health's adjusted earnings per share data for the three months ended in Jun. 2026 was $0.400. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.55 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Astrana Health's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Astrana Health was 64.60% per year. The lowest was -5.60% per year. And the median was 8.40% per year.

As of today (2026-08-10), Astrana Health's current stock price is $37.47. Astrana Health's E10 for the quarter that ended in Jun. 2026 was $0.55. Astrana Health's Shiller PE Ratio of today is 68.13.

During the past 13 years, the highest Shiller PE Ratio of Astrana Health was 1043.75. The lowest was 52.19. And the median was 169.20.


Astrana Health  (NAS:ASTH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Astrana Health's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=37.47/0.55
=68.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Astrana Health was 1043.75. The lowest was 52.19. And the median was 169.20.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Astrana Health E10 Related Terms


Astrana Health E10 Historical Data

* Premium members only.

The historical data trend for Astrana Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health E10 Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.72 -0.32 -0.04 0.15 0.33

Astrana Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.27 0.33 0.48 0.55

ASTH vs SNDA, SGRY, AVAH: E10 Comparison

For the Medical Care Facilities subindustry, Astrana Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Astrana Health's Shiller PE Ratio falls into.


ASTH
74GF Score
Astrana Health Inc ASTH
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Astrana Health's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.4/333.9520*333.9520
=0.400

Current CPI (Jun. 2026) = 333.9520.

Astrana Health Quarterly Data

per share eps CPI Adj_EPS
201609 -0.225 241.428 -0.311
201612 -0.287 241.432 -0.397
201703 -0.756 243.801 -1.036
201706 -0.599 244.955 -0.817
201709 -0.642 246.819 -0.869
201712 0.000 246.524 0.000
201803 0.066 249.554 0.088
201806 0.081 251.989 0.107
201809 0.240 252.439 0.317
201812 -0.100 251.233 -0.133
201903 0.004 254.202 0.005
201906 0.090 256.143 0.117
201909 0.100 256.759 0.130
201912 0.180 256.974 0.234
202003 0.110 258.115 0.142
202006 0.190 257.797 0.246
202009 0.450 260.280 0.577
202012 0.270 260.474 0.346
202103 0.300 264.877 0.378
202106 0.280 271.696 0.344
202109 0.740 274.310 0.901
202112 0.300 278.802 0.359
202203 0.300 287.504 0.348
202206 0.260 296.311 0.293
202209 0.500 296.808 0.563
202212 -0.060 296.797 -0.068
202303 0.280 301.836 0.310
202306 0.280 305.109 0.306
202309 0.470 307.789 0.510
202312 0.260 306.746 0.283
202403 0.310 312.332 0.331
202406 0.400 314.175 0.425
202409 0.330 315.301 0.350
202412 -0.150 315.605 -0.159
202503 0.140 319.799 0.146
202506 0.190 322.561 0.197
202509 0.010 324.800 0.010
202512 0.120 324.054 0.124
202603 0.290 330.213 0.293
202606 0.400 333.952 0.400

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.55 mean?
Astrana Health (ASTH) has a E10 of $0.55 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Astrana Health and its competitors.
Is Astrana Health's E10 too high?
Astrana Health's current E10 is $0.55. Overall, Astrana Health has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's E10 compare to SNDA and SGRY?
Astrana Health's E10 of $0.55 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Astrana Health and its competitors. Astrana Health's current E10 is $0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $65.38, compared to a current price of $37.47 — trading 42.7% below its estimated fair value. The current E10 is $0.55. Astrana Health's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Astrana Health (ASTH), the current E10 is $0.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $37.47 is trading 42.7% below its estimated GF Value™ of $65.38. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • E10: $0.55
  • GF Value™: $65.38 vs. price of $37.47 (42.7% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
74GF Score

Get the complete analysis for ASTH

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.47
Price
$65.38
GF Value